Ignite Creation Date:
2025-12-24 @ 4:21 PM
Ignite Modification Date:
2025-12-29 @ 4:09 AM
Study NCT ID:
NCT04417166
Status:
RECRUITING
Last Update Posted:
2025-01-30
First Post:
2020-06-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma
Sponsor:
International Extranodal Lymphoma Study Group (IELSG)
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IELSG50
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |